Lexicon Pharmaceuticals LXRX Q2 2025 earnings
Reported August 6, 2025 · Before market open
Revenue$28.9MBeat by $23.1M
EPS$0.01Beat by $0.09
Revenue estimate$5.8M
EPS estimate-$0.08
Next report
Aug 5, 2026 (In 6 days)Revenue estimate$4.0M
EPS estimate-$0.06
Financials
Q2 2025Valuation & ratios
Segments
Versus estimates
Revenue
Diluted EPS
Ask the moment Lexicon Pharmaceuticals reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Lexicon Pharmaceuticals report Q2 2025 earnings?
- Lexicon Pharmaceuticals (LXRX) reported Q2 2025 earnings on August 6, 2025 before market open.
- What were Lexicon Pharmaceuticals's Q2 2025 revenue and EPS?
- Lexicon Pharmaceuticals reported revenue of $28.9M and eps of $0.01 for Q2 2025.
- Did Lexicon Pharmaceuticals beat estimates in Q2 2025?
- Revenue beat the consensus estimate of $5.8M by $23.1M. EPS beat the consensus estimate of $-0.08 by $0.09.
- How did Lexicon Pharmaceuticals's Q2 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 1652.6% from $1.6M a year earlier.
- Where can I find Lexicon Pharmaceuticals's Q2 2025 SEC filings?
- You can read the 10-Q periodic report (0001628280-25-038340) directly on SEC EDGAR. The filing index links above go to sec.gov.